Investigating changes in vital signs in neonates

  • Research type

    Research Study

  • Full title

    Neo-vital: Investigating changes in vital signs in neonates

  • IRAS ID

    298347

  • Contact name

    Caroline Hartley

  • Contact email

    caroline.hartley@paediatrics.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Duration of Study in the UK

    1 years, 4 months, 29 days

  • Research summary

    1 in 7 babies require neonatal care. During their time in hospital their vital signs (such as heart rate, breathing rate and oxygen saturation) are continuously monitored as part of standard care. Many factors lead to changes in vital signs, for example, medical procedures such as blood tests can result in brief increases in heart rate. Medication can also alter vital signs, either as an intended effect or as a side effect. However, different infants will respond in different ways to both procedures and medication. Predicting how an individual infant may respond could lead to better individualised care for infants. For example, using an infant’s baseline vital signs to predict whether they will experience cardiorespiratory side effects from a particular drug could mean that doctors could choose an alternative safer treatment plan. To develop these predictive models, we first need to better understand how infants’ vital signs are affected by different procedures and drugs, and how these effects are impacted by other factors such as infection, other pathologies, interaction between drugs and age.

    Despite their routine use in hospital neonatal units, detailed electronic records of vital signs are often not recorded. Often, only major events or average values are stated on clinical records. Subtle changes in vital signs are therefore missed, and more complex analysis that may reveal important predictive features within the data is not possible. In this study we will electronically record infant vital signs across longer time periods and during a variety of clinically-necessary procedures and administration of drugs, to explore how these impact vital signs and are altered by factors such as age and pathology.

  • REC name

    North West - Greater Manchester East Research Ethics Committee

  • REC reference

    23/NW/0155

  • Date of REC Opinion

    7 Jul 2023

  • REC opinion

    Further Information Favourable Opinion